Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures or patient choices.…
6 articles, transcripts, and reports
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures or patient choices.…
Bausch Health Companies Inc. (NYSE: BHC) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Arthur Shannon — Senior Vice President, Head of Investor Relations and…
Bausch Health Companies Inc. (NYSE: BHC) Q3 2020 earnings call dated Nov. 03, 2020 Corporate Participants: Arthur Shannon — Senior Vice President of Investor Relations and Global…
Bausch Health Companies Inc. (NYSE: BHC) reported a wider loss in the first quarter of 2020 due to lower income taxes benefit and higher costs…
Bausch Health Companies Inc. (BHC) Q4 2019 earnings call dated Feb. 19, 2020 Corporate Participants: Arthur J. Shannon — Senior Vice President and Head of Investor Relations…
— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per…